168 related articles for article (PubMed ID: 19341705)
21. Comment on "Tumor growth need not be driven by rare cancer stem cells".
Kennedy JA; Barabé F; Poeppl AG; Wang JC; Dick JE
Science; 2007 Dec; 318(5857):1722; author reply 1722. PubMed ID: 18079385
[TBL] [Abstract][Full Text] [Related]
22. Characterization of side population cells in human malignant mesothelioma cell lines.
Kai K; D'Costa S; Yoon BI; Brody AR; Sills RC; Kim Y
Lung Cancer; 2010 Nov; 70(2):146-51. PubMed ID: 20493579
[TBL] [Abstract][Full Text] [Related]
23. Tumor initiating potential of side population cells in human gastric cancer.
Fukuda K; Saikawa Y; Ohashi M; Kumagai K; Kitajima M; Okano H; Matsuzaki Y; Kitagawa Y
Int J Oncol; 2009 May; 34(5):1201-7. PubMed ID: 19360333
[TBL] [Abstract][Full Text] [Related]
24. Identification of murine and human acute myeloid leukemia stem cells.
Deshpande AJ; Ahmed F; Buske C
Methods Mol Biol; 2009; 568():21-35. PubMed ID: 19582419
[TBL] [Abstract][Full Text] [Related]
25. Isolation and characterization of cells with neurogenic potential from adult skeletal muscle.
Vourc'h P; Romero-Ramos M; Chivatakarn O; Young HE; Lucas PA; El-Kalay M; Chesselet MF
Biochem Biophys Res Commun; 2004 May; 317(3):893-901. PubMed ID: 15081424
[TBL] [Abstract][Full Text] [Related]
26. Phenotype plasticity rather than repopulation from CD90/CK14+ cancer stem cells leads to cisplatin resistance of urothelial carcinoma cell lines.
Skowron MA; Niegisch G; Fritz G; Arent T; van Roermund JG; Romano A; Albers P; Schulz WA; Hoffmann MJ
J Exp Clin Cancer Res; 2015 Nov; 34():144. PubMed ID: 26606927
[TBL] [Abstract][Full Text] [Related]
27. Impact of chicken thrombopoietin and its receptor c-Mpl on hematopoietic cell development.
Bartunek P; Karafiat V; Bartunkova J; Pajer P; Dvorakova M; Kralova J; Zenke M; Dvorak M
Exp Hematol; 2008 Apr; 36(4):495-505. PubMed ID: 18243490
[TBL] [Abstract][Full Text] [Related]
28. Recurrence cancer stem cells--made by cell fusion?
Dittmar T; Nagler C; Schwitalla S; Reith G; Niggemann B; Zänker KS
Med Hypotheses; 2009 Oct; 73(4):542-7. PubMed ID: 19564079
[TBL] [Abstract][Full Text] [Related]
29. Bilineage acute leukemia of T-lymphoid and myeloid lineages.
Kobayashi N; Matsuda K; Sakashita K; Matsuzaki S; Iwasaki R; Koike K
Haematologica; 2004 Sep; 89(9):1139-41. PubMed ID: 15377477
[TBL] [Abstract][Full Text] [Related]
30. [Preliminary research of hepatocarcinoma stem cell markers].
Yan Z; Fang CH; Gao P
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1304-6. PubMed ID: 16982441
[TBL] [Abstract][Full Text] [Related]
31. Stem cells in cancer: instigators and propagators?
Alison MR; Islam S; Wright NA
J Cell Sci; 2010 Jul; 123(Pt 14):2357-68. PubMed ID: 20592182
[TBL] [Abstract][Full Text] [Related]
32. Chemokines in neuroectodermal development and their potential implication in cancer stem cell-driven metastasis.
Civenni G; Sommer L
Semin Cancer Biol; 2009 Apr; 19(2):68-75. PubMed ID: 19084599
[TBL] [Abstract][Full Text] [Related]
33. Decontamination of leukemic cells and enrichment of germ cells from testicular samples from rats with Roser's T-cell leukemia by flow cytometric sorting.
Hou M; Andersson M; Zheng C; Sundblad A; Söder O; Jahnukainen K
Reproduction; 2007 Dec; 134(6):767-79. PubMed ID: 18042634
[TBL] [Abstract][Full Text] [Related]
34. Tumor growth need not be driven by rare cancer stem cells.
Kelly PN; Dakic A; Adams JM; Nutt SL; Strasser A
Science; 2007 Jul; 317(5836):337. PubMed ID: 17641192
[TBL] [Abstract][Full Text] [Related]
35. Is tumor growth sustained by rare cancer stem cells or dominant clones?
Adams JM; Strasser A
Cancer Res; 2008 Jun; 68(11):4018-21. PubMed ID: 18519656
[TBL] [Abstract][Full Text] [Related]
36. Die hard: are cancer stem cells the Bruce Willises of tumor biology?
Fábián A; Barok M; Vereb G; Szöllosi J
Cytometry A; 2009 Jan; 75(1):67-74. PubMed ID: 19051297
[TBL] [Abstract][Full Text] [Related]
37. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
38. CD90 is identified as a marker for cancer stem cells in high-grade gliomas using tissue microarrays.
Parry PV; Engh JA
Neurosurgery; 2012 Apr; 70(4):N23-4. PubMed ID: 22426060
[No Abstract] [Full Text] [Related]
39. CD90 a potential cancer stem cell marker and a therapeutic target.
Shaikh MV; Kala M; Nivsarkar M
Cancer Biomark; 2016; 16(3):301-7. PubMed ID: 27062695
[TBL] [Abstract][Full Text] [Related]
40. Stem cell properties and the side population cells as a target for interferon-alpha in adult T-cell leukemia/lymphoma.
Kayo H; Yamazaki H; Nishida H; Dang NH; Morimoto C
Biochem Biophys Res Commun; 2007 Dec; 364(4):808-14. PubMed ID: 17977513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
